id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-4315	Dattola, Annunziata; Tolone, Martina; Amore, Emanuele; Bennardo, Luigi; Amato, Simone; Grieco, Teresa; Richetta, Antonio Giovanni; Pellacani, Giovanni; Skroza, Nevena; Nisticò, Steven Paul	Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab	2024	6	.pdf	application/pdf	4577	394	64	Gutermuth J, Pink AE, Worm M, Soldbro L, Bjerregård Øland C, Weidinger S. et al. Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, random- ized, phase III clinical trial (ECZTRA 7). In moderate to severe cases of AD (20% of AD patients), current therapeutic approaches may range from the use of: phototherapy, corticosteroids, methotrex- ate, cyclosporine, mycophenolate mofetil and azathioprine.	cache/dpc-4315.pdf	txt/dpc-4315.txt